anti hbc Search Results


94
Bio-Rad elisa
Elisa, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa/product/Bio-Rad
Average 94 stars, based on 1 article reviews
elisa - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Valiant Co Ltd anti hbc competitive elisa
Anti Hbc Competitive Elisa, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti hbc competitive elisa/product/Valiant Co Ltd
Average 90 stars, based on 1 article reviews
anti hbc competitive elisa - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

92
Austral Biologicals anti hbc antibody
Anti Hbc Antibody, supplied by Austral Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti hbc antibody/product/Austral Biologicals
Average 92 stars, based on 1 article reviews
anti hbc antibody - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

hbc  (Biorbyt)
93
Biorbyt hbc
Hbc, supplied by Biorbyt, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hbc/product/Biorbyt
Average 93 stars, based on 1 article reviews
hbc - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Aviva Systems anti hbv core hbcag
Characteristics of HBV replication in HBVs-mut and HBV-s-rec strains.
Anti Hbv Core Hbcag, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti hbv core hbcag/product/Aviva Systems
Average 90 stars, based on 1 article reviews
anti hbv core hbcag - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
Bio-Rad monolisa anti hbc plus

Monolisa Anti Hbc Plus, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monolisa anti hbc plus/product/Bio-Rad
Average 94 stars, based on 1 article reviews
monolisa anti hbc plus - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

92
Valiant Co Ltd hbc igm elisas 4 0

Hbc Igm Elisas 4 0, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hbc igm elisas 4 0/product/Valiant Co Ltd
Average 92 stars, based on 1 article reviews
hbc igm elisas 4 0 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

90
Blackwell Science Ltd anti-hcv antibodies

Anti Hcv Antibodies, supplied by Blackwell Science Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-hcv antibodies/product/Blackwell Science Ltd
Average 90 stars, based on 1 article reviews
anti-hcv antibodies - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Siemens Healthineers anti-hbc

Anti Hbc, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-hbc/product/Siemens Healthineers
Average 90 stars, based on 1 article reviews
anti-hbc - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Beijing Hotgen Biotech Co Ltd hepatitis b core antibody (anti-hbc)

Hepatitis B Core Antibody (Anti Hbc), supplied by Beijing Hotgen Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hepatitis b core antibody (anti-hbc)/product/Beijing Hotgen Biotech Co Ltd
Average 90 stars, based on 1 article reviews
hepatitis b core antibody (anti-hbc) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Abbott Laboratories anti-hbc

Anti Hbc, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-hbc/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
anti-hbc - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
DRG Instruments GmbH anti-hbc

Anti Hbc, supplied by DRG Instruments GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-hbc/product/DRG Instruments GmbH
Average 90 stars, based on 1 article reviews
anti-hbc - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Characteristics of HBV replication in HBVs-mut and HBV-s-rec strains.

Journal: Scientific Reports

Article Title: Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen

doi: 10.1038/srep24865

Figure Lengend Snippet: Characteristics of HBV replication in HBVs-mut and HBV-s-rec strains.

Article Snippet: The following antibodies were used: anti-HBV core (HBcAg) (16), HBsAg antibody (Aviva Systems Biology, San Diego, CA, USA) and Gapdh (Cell Signaling, Danvers, MA, USA).

Techniques:

Two-month-old transgenic HBV (HBV-s-mut) mice were given 200 μl of small interfering RNA (siRNA) (4 μg/g body weight) via tail vein injection. Mice were put to death 2 days or 10 days after injection, and liver and blood samples were collected. RNA was extracted from liver tissue, and changes in HBV mRNA expression were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR) ( A ). Copy numbers were normalized to 100,000 copies of glyceraldehyde 3-phosphate dehydrogenase ( Gapdh ) (mean ± SEM). Serum was prepared, and hepatitis B excretory antigen (HBeAg) levels were measured by chemiluminescent microparticle immunoassay (CMIA) (mean ± SEM) ( B ). Proteins were extracted from liver tissue, and HBcAg was detected by western blot analysis ( C ). Densitometric analysis was performed ( D ). Liver tissue was fixed, embedded in paraffin, and sectioned; it was then stained with HBcAg/hematoxylin. Images (20x optical magnification) show cells from wild type (WT) mice, from HBV-s-mut mice given non-template control siRNA (siNC), and from HBV-s-mut mice given HBxAg-targeting siRNA (siHBV) ( E ). DNA was extracted from liver tissue, and changes in DNA replication of HBV were determined by Southern blot analysis ( F ). Group size n = 3 ( A , C/D ) or exemplarily n = 2 ( B , F ) animals; *p < 0.05, ***p < 0.001; d, day; w/o, without treatment.

Journal: Scientific Reports

Article Title: Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen

doi: 10.1038/srep24865

Figure Lengend Snippet: Two-month-old transgenic HBV (HBV-s-mut) mice were given 200 μl of small interfering RNA (siRNA) (4 μg/g body weight) via tail vein injection. Mice were put to death 2 days or 10 days after injection, and liver and blood samples were collected. RNA was extracted from liver tissue, and changes in HBV mRNA expression were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR) ( A ). Copy numbers were normalized to 100,000 copies of glyceraldehyde 3-phosphate dehydrogenase ( Gapdh ) (mean ± SEM). Serum was prepared, and hepatitis B excretory antigen (HBeAg) levels were measured by chemiluminescent microparticle immunoassay (CMIA) (mean ± SEM) ( B ). Proteins were extracted from liver tissue, and HBcAg was detected by western blot analysis ( C ). Densitometric analysis was performed ( D ). Liver tissue was fixed, embedded in paraffin, and sectioned; it was then stained with HBcAg/hematoxylin. Images (20x optical magnification) show cells from wild type (WT) mice, from HBV-s-mut mice given non-template control siRNA (siNC), and from HBV-s-mut mice given HBxAg-targeting siRNA (siHBV) ( E ). DNA was extracted from liver tissue, and changes in DNA replication of HBV were determined by Southern blot analysis ( F ). Group size n = 3 ( A , C/D ) or exemplarily n = 2 ( B , F ) animals; *p < 0.05, ***p < 0.001; d, day; w/o, without treatment.

Article Snippet: The following antibodies were used: anti-HBV core (HBcAg) (16), HBsAg antibody (Aviva Systems Biology, San Diego, CA, USA) and Gapdh (Cell Signaling, Danvers, MA, USA).

Techniques: Transgenic Assay, Small Interfering RNA, Injection, Expressing, Reverse Transcription, Polymerase Chain Reaction, Quantitative RT-PCR, Western Blot, Staining, Control, Southern Blot

Transgenic HBV (HBV-s-mut) mice were crossbred with Toll-like receptor 3-deficient (Tlr3−/−) mice. Two-month-old HBV-negative littermates (WT), Tlr3−/− mice, HBV-s-mut mice, and HBV-s-mut/Tlr3−/− mice were put to death. RNA was extracted from liver tissue and changes in gene expression of Ifnb1 ( A ), Isg15 ( B ), Ifit1 ( C ), Tlr3 ( G ) and HBV mRNA expression ( D ) were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Copy numbers were normalized to 100,000 copies of Gapdh (mean ± SEM). DNA was extracted from liver tissue, and changes in HBV DNA were quantified by PCR ( E ). Proteins were extracted from liver tissue, HBcAg was detected by western blot analysis and densitometric analysis was performed ( F ). Group size n = 8 ( A – D ), n = 4 ( E , G ) and n = 3 ( F ) animals; *p < 0.05, **p < 0.01, ***p < 0.001; HBV-s-mut, Tg1.4HBV-S-Mut3; WT, wild type.

Journal: Scientific Reports

Article Title: Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen

doi: 10.1038/srep24865

Figure Lengend Snippet: Transgenic HBV (HBV-s-mut) mice were crossbred with Toll-like receptor 3-deficient (Tlr3−/−) mice. Two-month-old HBV-negative littermates (WT), Tlr3−/− mice, HBV-s-mut mice, and HBV-s-mut/Tlr3−/− mice were put to death. RNA was extracted from liver tissue and changes in gene expression of Ifnb1 ( A ), Isg15 ( B ), Ifit1 ( C ), Tlr3 ( G ) and HBV mRNA expression ( D ) were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Copy numbers were normalized to 100,000 copies of Gapdh (mean ± SEM). DNA was extracted from liver tissue, and changes in HBV DNA were quantified by PCR ( E ). Proteins were extracted from liver tissue, HBcAg was detected by western blot analysis and densitometric analysis was performed ( F ). Group size n = 8 ( A – D ), n = 4 ( E , G ) and n = 3 ( F ) animals; *p < 0.05, **p < 0.01, ***p < 0.001; HBV-s-mut, Tg1.4HBV-S-Mut3; WT, wild type.

Article Snippet: The following antibodies were used: anti-HBV core (HBcAg) (16), HBsAg antibody (Aviva Systems Biology, San Diego, CA, USA) and Gapdh (Cell Signaling, Danvers, MA, USA).

Techniques: Transgenic Assay, Gene Expression, Expressing, Reverse Transcription, Polymerase Chain Reaction, Quantitative RT-PCR, Western Blot

Two-month-old male transgenic HBV (HBV-s-mut) mice and their wild type (WT) littermates were given Toll-like receptor 3 (Tlr3) ligand polyinosinic-polycytidylic acid (Poly[I:C]; 4 μg/g body weight) via tail vein injection. Mice were put to death 6 h or 24 h after injection. RNA was extracted, and changes in gene expression of Ifnb1 ( A ), Isg15 ( B ), and HBV ( C ) were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Copy numbers were normalized to 100,000 copies of Gapdh (mean ± SEM). DNA was extracted from liver tissue, and changes in HBV DNA were quantified by PCR ( D ). Proteins were extracted from liver tissue, HBcAg was detected by western blot analysis and densitometric analysis was performed ( E ). Group size n = 3 animals; *p < 0.05, **p < 0.01, ***p < 0.001; HBV-s-mut, Tg1.4HBV-S-Mut3; w/o, without treatment.

Journal: Scientific Reports

Article Title: Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen

doi: 10.1038/srep24865

Figure Lengend Snippet: Two-month-old male transgenic HBV (HBV-s-mut) mice and their wild type (WT) littermates were given Toll-like receptor 3 (Tlr3) ligand polyinosinic-polycytidylic acid (Poly[I:C]; 4 μg/g body weight) via tail vein injection. Mice were put to death 6 h or 24 h after injection. RNA was extracted, and changes in gene expression of Ifnb1 ( A ), Isg15 ( B ), and HBV ( C ) were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Copy numbers were normalized to 100,000 copies of Gapdh (mean ± SEM). DNA was extracted from liver tissue, and changes in HBV DNA were quantified by PCR ( D ). Proteins were extracted from liver tissue, HBcAg was detected by western blot analysis and densitometric analysis was performed ( E ). Group size n = 3 animals; *p < 0.05, **p < 0.01, ***p < 0.001; HBV-s-mut, Tg1.4HBV-S-Mut3; w/o, without treatment.

Article Snippet: The following antibodies were used: anti-HBV core (HBcAg) (16), HBsAg antibody (Aviva Systems Biology, San Diego, CA, USA) and Gapdh (Cell Signaling, Danvers, MA, USA).

Techniques: Transgenic Assay, Injection, Gene Expression, Reverse Transcription, Polymerase Chain Reaction, Quantitative RT-PCR, Western Blot

Journal: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz

Article Title: Sicherheit von Blut und Blutprodukten: Testmethoden zum Nachweis der Hepatitisviren B, C und E

doi: 10.1007/s00103-021-03480-0

Figure Lengend Snippet:

Article Snippet: Anti-HBc , Monolisa Anti-HBc Plus , Bio-Rad , Indirekt (Anti-Human-IgG, -IgM) , ELISA.

Techniques: Marker, Multiplex Assay, Diagnostic Assay, Virus, Enzyme-linked Immunosorbent Assay, Sandwich ELISA

Journal: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz

Article Title: Sicherheit von Blut und Blutprodukten: Testmethoden zum Nachweis der Hepatitisviren B, C und E

doi: 10.1007/s00103-021-03480-0

Figure Lengend Snippet:

Article Snippet: Anti-HBc , Advia Centaur HBc Total 2 (HBcT2) , Siemens Healthcare Diagnostics , Sandwich , CLIA.

Techniques: Marker

Journal: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz

Article Title: Sicherheit von Blut und Blutprodukten: Testmethoden zum Nachweis der Hepatitisviren B, C und E

doi: 10.1007/s00103-021-03480-0

Figure Lengend Snippet:

Article Snippet: Anti-HBc , Advia Centaur HBc Total 2 (HBcT2) , Siemens Healthcare Diagnostics , Sandwich , CLIA.

Techniques: Marker, Multiplex Assay, Diagnostic Assay, Enzyme-linked Immunosorbent Assay, Sandwich ELISA

Journal: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz

Article Title: Sicherheit von Blut und Blutprodukten: Testmethoden zum Nachweis der Hepatitisviren B, C und E

doi: 10.1007/s00103-021-03480-0

Figure Lengend Snippet:

Article Snippet: Anti-HBc , Advia Centaur HBc Total 2 (HBcT2) , Siemens Healthcare Diagnostics , Sandwich , CLIA.

Techniques: